Generated: January 17, 2018
DrugPatentWatch Database Preview
Patent Applications for fingolimod
« Back to Dashboard
US Patent Applications for fingolimod
|US Patent Application
||Patent Filing Date
||Patent Application Status
|➤ Subscribe||➤ Subscribe||USE FOR 1,3-PROPANEDIOL DERIVATIVES||2001-07-03||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2014-12-22|
|➤ Subscribe||➤ Subscribe||PRODUCTION OF 2-AMINO-2-[2-(4-C2-20-ALKYL-PHENYL)ETHYL]PROPANE-1,3-DIOLS||2001-05-08||Patented Case||2003-07-24|
|➤ Subscribe||➤ Subscribe||PHOSPHATE DERIVATIVES AS IMMUNOREGULATORY AGENTS||2001-08-30||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2010-09-20|
|➤ Subscribe||➤ Subscribe||ALPHA4BETA1 AND ALPHA4BETA7 INTEGRIN INHIBITORS||2001-03-09||Abandoned -- Failure to Pay Issue Fee||2003-01-09|
|➤ Subscribe||➤ Subscribe||COMPOSITIONS AND METHODS OF USING COMPOSITIONS WITH ACCELERATED LYMPHOCYTE HOMING IMMUNOSUPPRESSIVE PROPERTIES||1999-06-15||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2008-01-21|
|➤ Subscribe||➤ Subscribe||Combinations of immunosupressive agents for the treatment or prevention of graft rejections||2001-11-07||Abandoned -- Failure to Respond to an Office Action||2005-09-16|
|➤ Subscribe||➤ Subscribe||Anti-CD3 immunotoxins and therapeutic uses therefor||2000-01-10||Abandoned -- After Examiner's Answer or Board of Appeals Decision||2007-11-13|
|➤ Subscribe||➤ Subscribe||Tolerance-inducing thy-marrow composite tissue construct and organ||2001-04-12||Abandoned -- Failure to Respond to an Office Action||2003-08-11|
|➤ Subscribe||➤ Subscribe||EDG: MODULATORS OF LYMPHOCYTE ACTIVATION AND MIGRATION||2001-10-03||Patented Case||2009-04-01|
|➤ Subscribe||➤ Subscribe||Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection||2002-06-07||Abandoned -- Failure to Respond to an Office Action||2006-03-20|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.